DiaMedica Therapeutics Inc. Common Stock (DMAC) is a publicly traded Healthcare sector company. As of September 23, 2026, DMAC trades at $7.78 with a market cap of $391.50M and a P/E ratio of -10.91. DMAC moved +7.16% today. Year to date, DMAC is -2.26%; over the trailing twelve months it is +11.46%. Its 52-week range spans $3.19 to $10.42. Analyst consensus is strong buy with an average price target of $13.00. Rallies surfaces DMAC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DMAC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DMAC recently traded at $7.78. Market cap is $391.50M. P/E ratio is -10.91. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $7.78 |
| Market Cap | $391.50M |
| P/E Ratio |
| -10.91 |
| EPS | $-0.70 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $10.42 |
|---|
| 52-Week Low | $3.19 |
|---|
| Volume | 274.94K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $-32.77M |
|---|
| Gross Margin | 0.00% |
|---|
3 analysts cover DMAC: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.00.